Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06109194 · ClinicalTrials.gov registry record · NA
Immediate Effect of Ankle Mobilization on Active Range of Motion and Gait in Subacute Stroke
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06109194: Completed NA study, sponsored by Loma Linda University.
NCT06109194 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06109194, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this observational study is to determine the effect of ankle joint mobilization on active range of motion and gait in subacute first-time stroke. The main questions it aims to answer are: * What is the effect of ankle joint mobilization on active range of motion in the ankle and gait qualities? * What is the effect of ankle joint mobilization on self-perceived gait ability? Participants will receive physical therapy interventions of: * Grade III ankle joint mobilization * stretching of ankle plantarflexor muscles * ankle muscle activation training * assisted gait as part of assessment Study design is to measure conditions before and after the intervention to determine effect(s) of one treatment dose, completed within one session of 90 minutes.
Primary Outcome
ankle (talocrural) joint dorsiflexion movement of the foot away from plantarflexion end-range, measured by goniometry in seated position, by a physical therapist with 25 years' experience. Normal ankle ranges are 0 to 45 degrees from neutral for plantarflexion and 0-25 degrees from neutral for dorsiflexion. 0 to 15 degrees of dorsiflexion is needed for functionally efficient gait. Both passive and active ankle dorsiflexion range of motion are expected to increase, but be less than normal.
Interventions
- OTHER Joint mobilization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-12-19 |
| Est. Completion | 2024-06-10 |
| Phase | NA |
What the finished NCT06109194 record still lists
NCT06109194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Joint mobilization is the first listed.
NCT06109194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06109194 about?
NCT06109194 is a clinical study titled "Immediate Effect of Ankle Mobilization on Active Range of Motion and Gait in Subacute Stroke". The goal of this observational study is to determine the effect of ankle joint mobilization on active range of motion and gait in subacute first-time stroke. The main questions it aims to answer are: * What is the effect of ankle joint mobilization on active range of motion in the ankle and gait qu...
What is the current status of trial NCT06109194?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-12-19. Estimated completion is 2024-06-10.
What interventions are being tested in trial NCT06109194?
The interventions under investigation include: Joint mobilization (OTHER).
Who is sponsoring clinical trial NCT06109194?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06109194's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI